Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis - Dose Escalation Phase: Histologically or cytologically confirmed diagnosis of advanced solid tumor that is resistant to standard therapy or for which no standard therapy is available.
Diagnosis - Dose Expansion Phase: Histologically or cytologically confirmed advanced RCC with a component of clear cell subtype
Dose Expansion Phase: at least one measureable lesion as defined by RECIST \[Response Evaluation Criterion in Solid Tumors\] version 1.1.
ECOG \[Eastern Cooperative Oncology Group\] Performance Status 0 or 1.
You may not be if
Major surgery \<4 weeks or radiation therapy \<2 weeks of patient registration.
History of or known active seizure disorder, brain metastases, spinal cord compression, or carcinomatous meningitis, or new evidence of brain or leptomeningeal disease.
Dose Expansion Phase only: diagnosis of any other malignancy within 2 years prior to registration.
Clareo Health | A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
